Antimicrobial Peptides: Primeval Molecules or Future Drugs?
article has not abstract
Vyšlo v časopise:
Antimicrobial Peptides: Primeval Molecules or Future Drugs?. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001067
Kategorie:
Pearls
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001067
Souhrn
article has not abstract
Zdroje
1. GiulianiA
PirriG
NicolettoS
2007
Antimicrobial peptides: an overview of a promising class of therapeutics.
Cent Eur J Biol
2
1
33
2. ZasloffM
2002
Antimicrobial peptides of multicellular organisms.
Nature
415
389
395
3. ShaiY
2002
From innate immunity to de-novo designed antimicrobial peptides.
Curr Pharm Des
8
715
725
4. BalsR
WilsonJM
2003
Cathelicidins–a family of multifunctional antimicrobial peptides.
Cell Mol Life Sci
60
711
720
5. KavanaghK
DowdS
2004
Histatins: antimicrobial peptides with therapeutic potential.
J Pharm Pharmacol
56
285
289
6. KlotmanME
ChangTL
2006
Defensins in innate antiviral immunity.
Nat Rev Immunol
6
447
456
7. HarrisM
Mora-MontesHM
GowNA
CootePJ
2009
Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface.
Microbiology
155
1058
1070
8. YeamanMR
YountNY
2003
Mechanisms of antimicrobial peptide action and resistance.
Pharmacol Rev
55
27
55
9. BradshawJ
2003
Cationic antimicrobial peptides : issues for potential clinical use.
BioDrugs
17
233
240
10. PeschelA
SahlHG
2006
The co-evolution of host cationic antimicrobial peptides and microbial resistance.
Nat Rev Microbiol
4
529
536
11. TangYQ
YeamanMR
SelstedME
2002
Antimicrobial peptides from human platelets.
Infect Immun
70
6524
6533
12. BrownKL
HancockRE
2006
Cationic host defense (antimicrobial) peptides.
Curr Opin Immunol
18
24
30
13. DiamondG
BeckloffN
WeinbergA
KisichKO
2009
The roles of antimicrobial peptides in innate host defense.
Curr Pharm Des
15
2377
2392
14. MaderJS
HoskinDW
2006
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment.
Expert Opin Investig Drugs
15
933
946
15. MookherjeeN
HancockRE
2007
Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.
Cell Mol Life Sci
64
922
933
16. SteinstraesserL
KoehlerT
JacobsenF
DaigelerA
GoertzO
2008
Host defense peptides in wound healing.
Mol Med
14
528
537
17. MullardA
2008
Immune evasion: Overcoming defensins.
Nat Rev Micro
6
415
415
18. SperandioB
RegnaultB
GuoJ
ZhangZ
StanleySLJr
2008
Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression.
J Exp Med
205
1121
1132
19. MeillerTF
HubeB
SchildL
ShirtliffME
ScheperMA
2009
A novel immune evasion strategy of Candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.
PLoS ONE
4
e5039
doi:10.1371/journal.pone.0005039
20. NaglikJR
ChallacombeSJ
HubeB
2003
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.
Microbiol Mol Biol Rev
67
400
428
21. HelmerhorstEJ
VenuleoC
SanglardD
OppenheimFG
2006
Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.
Antimicrob Agents Chemother
50
1100
1103
22. RoyH
DareK
IbbaM
2009
Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids.
Mol Microbiol
71
547
550
23. BermanHM
WestbrookJ
FengZ
GillilandG
BhatTN
2000
The Protein Data Bank.
Nucleic Acids Res
28
235
242
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 10
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
- Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
- Antimicrobial Peptides: Primeval Molecules or Future Drugs?
- Crystal Structure of DotD: Insights into the Relationship between Type IVB and Type II/III Secretion Systems